Charles Brown, MD
Cardiovascular Disease · Jefferson Hills, PANPI 1336239664
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,000 of the $24,320 with a category attached, or 74.0%. 52 manufacturers reported payments, led by Abbott at 26.8% of the total. 2025 is the largest year on record at $7,478, 2.2 times the $3,346 reported in 2019. Among cardiovascular disease clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 683 payments — averaging $35.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Medtronic$3K
- Cardiovascular Systems Inc.$3K
- Johnson & Johnson$2K
- Pfizer$1K
- Boston Scientific$923
- plus $8K from 46 others
What the payments were for
- Consulting fees$1,5006%
- Speaking & faculty fees$2,0008%
- Travel & lodging$2,82012%
- Food & beverage$18,00074%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABSOLUTE PRO$3,500
- Peripheral Orbital Atherectomy System$2,147
- AVEIR$1,010
- Absolute Pro vascular stent system$402
- XACT$271
- Torus Stent Graft System$258
- ENDOCROSS Device$258
- Sublime 014 Rx PTA Balloon Dilatation Catheter$241
- Pounce Thrombectomy System$241
- Pounce Venous Thrombectomy System$241
- SAPIEN 3 Ultra RESILIA$226
- WATCHMAN FLX$183
- Edwards SAPIEN 3 Transcatheter Heart Valve$169
- FLOWTRIEVER CATHETER, S$156
- CT THROMBECTOMY SYSTEM KIT$156
- Diamondback Peripheral$148
- Coronary Orbital Atherectomy System$146
- BioMimics$146
- CoreValve Evolut$139
- Sublime Microcatheter, 018, 200cm, Straight$137
How this compares
$24,320 in reported general payments places this provider in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 272 | $278,051 |
| XareltoRivaroxaban | 89 | $94,016 |
| EntrestoSacubitril/Valsartan | 56 | $57,167 |
| JardianceEmpagliflozin | 36 | $36,843 |
| BrilintaTicagrelor | 32 | $29,353 |
| Repatha SyringeEvolocumab | 20 | $17,274 |
| Repatha SureclickEvolocumab | 12 | $17,118 |
| Metoprolol Succinate | 364 | $5,773 |
| Atorvastatin Calcium | 308 | $3,620 |
| ClopidogrelClopidogrel Bisulfate | 234 | $2,932 |
| Flecainide Acetate | 64 | $2,859 |
| Valsartan | 73 | $2,418 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 62 | $2,413 |
| Dofetilide | 13 | $2,351 |
| Rosuvastatin Calcium | 117 | $2,084 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,370 | $278,051272 claims |
| Johnson & JohnsonXarelto | $1,646 | $94,01689 claims |
| NovartisEntresto | $835 | $57,16756 claims |
| Boehringer IngelheimJardiance | $83 | $36,84336 claims |
| AstraZenecaBrilinta | $548 | $29,35332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Other cardiovascular disease in Jefferson Hills
- Gennady GeskinJefferson Hills$244K
- Amish MehtaJefferson Hills$132K
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Rhian DaviesYork$853K
- Sarang MangalmurtiBryn Mawr$728K
- Sabahat BokhariAllentown$578K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.